Could less steroid before chemo be safer and just as effective?
NCT ID NCT02776436
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving a lower dose of the steroid dexamethasone before the chemotherapy drug docetaxel can prevent allergic reactions with fewer side effects. The standard high dose can cause problems like high blood sugar, mood changes, and weakened immunity. Researchers tested different lower doses in 46 people with breast or prostate cancer to find a safer option that still works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Haga hospital
The Hague, Netherlands
-
Leiden university medical center
Leiden, Netherlands
-
Reinier de Graaf hospital
Delft, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a new tracer light up hidden prostate cancer?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could deep breaths before surgery ward off Post-Op confusion?
- Could ionized gas help fight breast cancer after surgery?